[Description]
CGCryoDerm™ is an allograft derived from donated human skin. The epidermis and dermis are removed from the subcutaneous layer of the skin during the recovery procedure. The tissue is then processed using a sodium chloride solution and detergent to remove the epidermis and all viable dermal cells while maintaining the original dermal collagen matrix. The cells are removed to minimize inflammation or immunorejection at the surgical site.

CGCryoDerm™ is then treated in a disinfection solution that combines detergents with acidic and antiseptic reagents to further clean the tissue so that it passed KGMP, USP<1116> for sterility. Finally, it is packaged in sterilized double pouch and envelope, it is cryopreserved.



[Advantage]
1. Safe
No immune rejection after acellularizing process.
CGCryoDerm™ meets the safety criteria of KFDA, US FDA, permiting saleability in the United States.

2. Effective
Equal or better uptake rates compared to other existing dermal matrix allograft and dermal matrix xenograft. 

3. Convenient
Custom-made sizes for the intended use



[Package]
GRAFT
Graftable 10 : 0.23-0.36mm thickness
Graftable 20 : 0.36-0.51mm thickness

Implant
Breast reconstruction (0.80-2.28mm thickness) : 4x12㎠



[Details]
View CGDerm CGCryoDerm brochure(pdf)